Plasma Plasmodium falciparum Histidine-rich Protein 2 Concentrations in Children With Malaria Infections of Differing Severity in Kilifi, Kenya
Open Access
- 9 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (7), e2415-e2423
- https://doi.org/10.1093/cid/ciaa1141
Abstract
Most previous studies support a direct link between total parasite load and the clinical severity of Plasmodium falciparum malaria infections. We estimated P. falciparum parasite loads in 3 groups of children with malaria infections of differing severity: (1) children with World Health Organization–defined severe malaria (n = 1544), (2) children admitted with malaria but without features of severity (n = 200), and (3) children in the community with asymptomatic parasitemia (n = 33). Peripheral parasitemias were highest in those with uncomplicated malaria (geometric mean [GM] parasite count, 111 064/μL; 95% confidence interval, CI, 86 798–141 819/μL), almost 3 times higher than in those with severe malaria (39 588/μL; 34 990–44 791/μL) and >100 times higher than in those with asymptomatic malaria (1092/μL; 523–2280/μL). However, the GM P. falciparum histidine-rich protein 2 (PfHRP2) values (95% CI) increased with severity, being 7 (4–12) ng/mL in asymptomatic malaria, 843 (655–1084) ng/mL in uncomplicated malaria, and 1369 (1244–1506) ng/mL in severe malaria. PfHRP2 concentrations were markedly lower in the subgroup of patients with severe malaria and concomitant invasive bacterial infections of blood or cerebrospinal fluid (GM concentration, 312 ng/mL; 95% CI, 175–557 ng/mL; P < .001) than in those without such infections (1439 ng/mL; 1307–1584; P < .001). The clinical severity of malaria infections related strongly to the total burden of P. falciparum parasites. A quantitative test for plasma concentrations of PfHRP2 could be useful in identifying children at the greatest clinical risk and identifying critically ill children in whom malaria is not the primary cause.Funding Information
- Wellcome Trust (203077/Z/16/Z)
- KEMRI-Wellcome Trust Research Programme (209265/Z/17/Z, 089275/Z/09/Z, 202800/Z/16/Z, 091758/Z/10)
- DELTAS Africa Initiative
- DEL-15-003
- African Academy of Sciences’s Alliance for Accelerating Excellence in Science in Africa
- New Partnership for Africa’s Development Planning and Coordinating Agency
- Wellcome Trust (203077/Z/16/Z)
- UK government
This publication has 45 references indexed in Scilit:
- Comparison of parasite sequestration in uncomplicated and severe childhood Plasmodium falciparum malariaJournal of Infection, 2013
- Lethal Malaria: Marchiafava and Bignami Were RightThe Journal of Infectious Diseases, 2013
- Defining Falciparum-Malaria-Attributable Severe Febrile Illness in Moderate-to-High Transmission Settings on the Basis of Plasma PfHRP2 ConcentrationThe Journal of Infectious Diseases, 2012
- Diagnosing Severe Falciparum Malaria in Parasitaemic African Children: A Prospective Evaluation of Plasma PfHRP2 MeasurementPLoS Medicine, 2012
- Plasma Plasmodium falciparum Histidine-Rich Protein-2 Concentrations Are Associated with Malaria Severity and Mortality in Tanzanian ChildrenPLOS ONE, 2012
- Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural KenyaPLOS ONE, 2010
- Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control studyThe Lancet, 2009
- Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malariaProceedings of the National Academy of Sciences of the United States of America, 2008
- Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2PLoS Medicine, 2005
- Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparumTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005